Study of Salirasib to Treat Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00531401
Recruitment Status : Completed
First Posted : September 18, 2007
Last Update Posted : June 9, 2011
Information provided by:
Concordia Pharmaceuticals, Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : November 2009